Market News / Story
ASP Isotopes Plans to Vote on Merger at ENDRA Life Sciences with 15.1% Stake
·
ASP Isotopes Inc. disclosed a 15.1% beneficial stake in ENDRA Life Sciences Inc.’s common stock. The filing, dated Oct. 08, 2026, details recent purchases and warrants that lift its voting power ahead of a special shareholder meeting. The position gives ASP Isotopes a platform to weigh in on ENDRA’s proposed merger and related approvals. Investor Intent ASP Isotopes, through LHE LNG Holdings LLC, plans to exercise 187,169 pre-funded warrants before the record date so it…